STAT!Ref New Edition and Supplemental Updates

New Edition:

Current Diagnosis and Treatment Surgery.

13th Ed. ©2010 McGraw-Hill Companies, Inc.

Authors/Editors: Gerard M. Doherty

To-the-point information on more than 1000 diseases and disorders surgeons are most likely to encounter. Authoritative, concise and completely current, CURRENT Diagnosis & Treatment Surgery features:

•Wide-ranging coverage that encompasses general surgery and all the important subspecialties including otolaryngology, urology, gynecology, orthopedics, plastic and reconstructive surgery and pediatrics

•References linked to recent journal articles

•Logical quick-find organization made even more accessible by a comprehensive index

•More than 600 informative photographs and illustrations

•Detailed treatment algorithms

•NEW Chapter on Training, Communication, Professionalism and Systems-Based Practice

•Completely rewritten chapters on Wound Healing, Anesthesia, Otolaryngology/Head & Neck Surgery, The Heart, Neurosurgery, Gynecology and Orthopedics

•Formerly called, "Current Surgical Diagnosis and Treatment"

Supplemental Updates:

AAFP Conditions A to Z

©2009 American Academy of Family Physicians

Authors/Editors: American Academy of Family Physicians

AAFP Conditions A to Z is a handy patient-information tool that’s been written and reviewed by physicians and patient education professionals at the American Academy of Family Physicians (AAFP). The AAFP is a national medical organization representing more than 93,700 family physicians, family practice residents and medical students.

Common conditions, treatments and health tips are presented concisely and informatively, and listed alphabetically or cross-searched in STAT!Ref online. Print the information for your patients to enhance understanding and health promotion.

ACP PIER®: Physicians' Information and Education Resource

©2009 ACP PIER: American College of Physicians

Authors/Editors: ACP PIER: American College of Physicians (ACP) © 2008 by the American College of Physicians

PIER© is a collection of over 400 evidence summaries published by the American College of Physicians. Each module provides authoritative guidance to improve the quality of care. Important features of PIER include:

•Truly evidenced-based

•Defines the current standard of care

•Frequently updated (Monthly Content Updates and Module Additions)

•Consistently structured for rapid access

•Search or browse by organ system

•Integrated drug reference (AHFS DI Essentials) Topics are selected by ACP based upon prevalence in clinical settings.

Evidence is then gathered by literature review and evaluated based on formal criteria. The level of evidence for each recommendation is displayed clearly within the application. PIER also includes topics in complementary and alternative medicine, ethical and legal issues, and procedures.

Medical Letter® On Drugs and Therapeutics, The

©2009-1995 The Medical Letter, Inc.

Authors/Editors: Mark Arbramwicz, MD et. al.

The Medical Letter on Drugs and Therapeutics is an independent, nonprofit publication that offers unbiased critical evaluations of drugs for physicians and other members of the health professions. This resource evaluates virtually all new drugs and also reviews older drugs when important new information becomes available on their usefulness or adverse effects. It is only available to single users online and covers the period from 1995-2008

AHFS DI® Essentials™

©2009 by the American Society of Health-System Pharmacists, Inc.

Authors/Editors: Gerald K. McEvoy, Pharm.D.

AHFS DI® Essentials™ offers healthcare professionals easy access to knowledge that is critical at the point of care. Essentials™ monographs draw on the meticulously evidence-based guidelines in the full AHFS DI® database, distilling essential information on prescription and key over-the-counter (OTC) drugs in an easy-to-use and highly structured outline format.

New Title, New Edition and Supplemental Updates: What's New in September 2009

New Titles:

Trauma Care: Initial Assessment and Management in the Emergency Department

©2008 Wiley-Blackwell

The often complex problems of the trauma patient present many challenges to front line emergency staff. Multiple injuries involving many systems of the body require careful and timely prioritization and intervention in the emergency department. Trauma Care provides emergency nurses with a practical guide to the systematic assessment and management of trauma patients, equipping them with the clinical knowledge and practical skills necessary to initially assess and care for the trauma patient in the emergency department trauma environment.

Atlas of Gastrointestinal Surgery, Vol. 1

2nd Edition ©2007 People's Medical Publishing House, USA

This is a beautiful, color surgical atlas, which will complete any surgeon's online library. The first edition was published 14 years ago, and this new edition reflects advances in surgical care, as well as improved illustrations and text.

The authors are authoritative leaders in surgery from the Johns Hopkins Hospital. The title describes the operative techniques on the foregut employed at this august institution. Many of the operations described were developed at Johns Hopkins. The atlas vividly depicts in color illustrations and clear language these surgical techniques, bringing them alive for the reader.

New Edition:

Ganong's Review of Medical Physiology

23rd Ed. ©2010 McGraw Hill Companies, Inc.

The field's most complete, current and engagingly written title on medical physiology -- now in full color. For more than four decades, Ganong's Review of Medical Physiology has been the leader in helping medical students and clinicians understand the fascinating subject of human and mammalian physiology. Concisely covering every important topic without sacrificing depth or readability, Ganong's delivers more detailed, clinically relevant, high-yield information per page than any similar title or review.

Supplemental Updates:

AHFS DI® Essentials™

©2009 by the American Society of Health-System Pharmacists, Inc.

AHFS DI® Essentials™ offers healthcare professionals easy access to knowledge that is critical at the point of care. Essentials™ monographs draw on the meticulously evidence-based guidelines in the full AHFS DI® database, distilling essential information on prescription and key over-the-counter (OTC) drugs in an easy-to-use and highly structured outline format.

ACP PIER, Journal Club & AHFS DI® Essentials™

©2009 by the American College of Physicians

A pre-appraised, evidence-based clinical tool that defines the standard of care, including value-added abstracts of original journal articles and drug treatment information.

•PIER (Physicians' Information and Education Resource) Integrated and authoritative EBM resources for the point-of-care and background reference.

•ACP Journal Club is the quintessential EBM journal that summarizes original research applicable to clinical cases.

•AHFS® DI Essentials™ distills the essential information from the larger AHFS Drug Information database.

ACP PIER & AHFS DI® Essentials™

©2009 ACP PIER: American College of Physicians

©2009 AHFS DI® Essentials™

PIER© is a collection of over 400 evidence summaries published by the American College of Physicians. Each module provides authoritative guidance to improve the quality of care.

ACP PIER®: Physicians' Information and Education Resource

©2009 ACP PIER: American College of Physicians

PIER© is a collection of over 400 evidence summaries published by the American College of Physicians. Each module provides authoritative guidance to improve the quality of care.

 

AHFS Drug Information®

©2009 American Society of Health-System Pharmacists

With the 2009 edition, the American Hospital Formulary Service® (AHFS™) marks over 50 years of continuous publication by the American Society of Health-System Pharmacists (ASHP). Each year, an average of over 60% of AHFS content is revised to help you provide the most accurate recommendations for your patients’ drug therapy.

 

Medical Letter® On Drugs and Therapeutics, The

©2009-1995 The Medical Letter, Inc.

The Medical Letter on Drugs and Therapeutics is an independent, nonprofit publication that offers unbiased critical evaluations of drugs for physicians and other members of the health professions. This resource evaluates virtually all new drugs and also reviews older drugs when important new information becomes available on their usefulness or adverse effects.

APhA DrugInfoLine®

©2009 American Pharmacists Association (APhA)

APhA DrugInfoLine® is a monthly newsletter of interpreted drug and pharmacotherapeutic information designed to keep frontline pharmacists current on the latest trends in the biomedical literature.

New Titles, New Edition and Supplemental Updates: August 2009

New Titles:

The Official Guide for Foreign-Educated Nurses: What You Need to Know about Nursing and Health Care in the United States

©2009 Springer Publishing Company

This title is the only guide to the United States health care system for nurses immigrating to this country as well as foreign-educated nurses who are already here.

 

Comprehensive Nursing Care for Parkinson's Disease

©2007 Springer Publishing Company

The incidence of Parkinson's is growing as the number of older adults making up the general population increases. The demand for nurses who specialize in the care of patients with movement disorders is also increasing and it is crucial that they have a comprehensive manual for patient care.

 

New Edition:

Clinical Neuroanatomy 26th Ed.

©2010 McGraw-Hill Companies, Inc.

Learn the essential aspects of neuroanatomy and its clinical relevance with the field's most concise, trusted and effective title.

 

 

Supplemental Updates:

ACP Journal Club

©2009 by the American College of Physicians

ACP Journal Club, published by the American College of Physicians, is the quintessential EBM journal, and is often positioned near the top of the EBM pyramid.

ACP Medicine

©2009 BC Decker

ACP Medicine is the first comprehensive reference to carry the name of the American College of Physicians. Developed to help busy physicians keep up with changing guidelines in primary care, ACP Medicine is a continually updated, evidence-based reference of internal medicine.

ACP PIER, Journal Club & AHFS DI® Essentials™

©2009 by the American College of Physicians

A pre-appraised, evidence-based clinical tool that defines the standard of care, including value-added abstracts of original journal articles and drug treatment information.

•PIER (Physicians' Information and Education Resource) Integrated and authoritative EBM resources for the point-of-care and background reference.

•ACP Journal Club is the quintessential EBM journal that summarizes original research applicable to clinical cases.

•AHFS® DI Essentials™ distills the essential information from the larger AHFS Drug Information database.

ACP PIER & AHFS DI® Essentials™

©2009 ACP PIER: American College of Physicians

©2009 AHFS DI® Essentials™

PIER© is a collection of over 400 evidence summaries published by the American College of Physicians. Each module provides authoritative guidance to improve the quality of care.

ACP PIER®: Physicians' Information and Education Resource

©2009 ACP PIER: American College of Physicians

PIER© is a collection of over 400 evidence summaries published by the American College of Physicians. Each module provides authoritative guidance to improve the quality of care.

ACS Surgery: Principles and Practice

©2009 B.C. Decker

Published by B.C. Decker in collaboration with the American College of Surgeons (ACS), this continually updated reference, noted for its problem solving approach and numerous illustrations, is geared to the surgeon in practice. Master surgeons outline their preferred core general surgical procedure techniques.

AHFS Drug Information®

©2009 American Society of Health-System Pharmacists

With the 2009 edition, the American Hospital Formulary Service® (AHFS™) marks over 50 years of continuous publication by the American Society of Health-System Pharmacists (ASHP). Each year, an average of over 60% of AHFS content is revised to help you provide the most accurate recommendations for your patients’ drug therapy.

AHFS DI® Essentials™

©2009 by the American Society of Health-System Pharmacists, Inc.

AHFS DI® Essentials™ offers healthcare professionals easy access to knowledge that is critical at the point of care. Essentials™ monographs draw on the meticulously evidence-based guidelines in the full AHFS DI® database, distilling essential information on prescription and key over-the-counter (OTC) drugs in an easy-to-use and highly structured outline format

 

INFECTIOUS DISEASES: The Clinician's Guide to Diagnosis, Treatment, and Prevention

©2007 WebMD Inc.

This resource, derived from ACP Medicine, provides practical guidance on a wide range of infectious diseases such as upper respiratory infections, STDs and meningitis as well as viral, bacterial and fungal infections. It includes more than 4,000 focused, practical and current recommendations in addition to halftone and color illustrations.

Medical Letter® On Drugs and Therapeutics, The

©2009-1995 The Medical Letter, Inc.

The Medical Letter on Drugs and Therapeutics is an independent, nonprofit publication that offers unbiased critical evaluations of drugs for physicians and other members of the health professions. This resource evaluates virtually all new drugs and also reviews older drugs when important new information becomes available on their usefulness or adverse effects. It is only available to single users online and covers the period from 1995-2008.*

AHFS DI® Essentials: What's New in April 2009

AHFS DI® Essentials

New Monographs:

None

Revised Monographs:

Abatacept: Biologic response modifier and disease-modifying antirheumatic drug (DMARD); a recombinant fusion protein.

Adalimumab: Biologic response modifier and disease-modifying antirheumatic drug (DMARD); a recombinant DNA-derived human immunoglobulin G1 (IgG1) monoclonal antibody specific for human tumor necrosis factor (TNF; TNF-a).

a1-Proteinase Inhibitor: A naturally occurring serine protease inhibitor.

Bismuth Salts: Antidiarrhea agent; antidyspepsia agent; internal deodorant.

Citrates: Alkalinizing agents.

Deferoxamine: Heavy metal antagonist; chelating agent for iron and aluminum.

Disopyramide: Antiarrhythmic agent (class IA).

Estradiol: Steroidal estrogen; a principal endogenous estrogen.

Estrogen-Progestin Combinations: Contraceptive combinations containing estrogenic and progestinic steroids.

Flucytosine: Antifungal; fluorinated pyrimidine analog structurally related to fluorouracil and floxuridine.

Fosphenytoin: Hydantoin-derivative anticonvulsant; prodrug of phenytoin.

Hydrocodone: Opiate agonist; phenanthrene derivative.

Isradipine: Calcium-channel blocking agent; dihydropyridine derivative.

Mycophenolate: Immunosuppressive agent.

Omeprazole: Acid- or proton-pump inhibitor; gastric antisecretory agent.

Phenytoin: Phenytoin is a hydantoin-derivative anticonvulsant.

Piperacillin/Tazobactam: Antibacterial; b-lactam antibiotic; fixed combination of piperacillin (an extended-spectrum penicillin) and tazobactam (a b-lactamase inhibitor).

Triptorelin: Antineoplastic agent; synthetic decapeptide analog of gonadotropin-releasing hormone (GnRH, luteinizing hormone-releasing hormone, gonadorelin); structurally related to leuprolide and goserelin.

AHFS DI® Essentials: What's New in March, 2009

AHFS DI® Essentials

New Monographs:

• None

Revised Monographs:

• Aluminum Chloride (Topical): Antiperspirant.
• Benzonatate: Local anesthetic antitussive agent.
• Cetuximab: Antineoplastic agent; a recombinant chimeric (human-murine) monoclonal antibody that binds to epidermal growth factor receptors (EGFR).
• Dextromethorphan: Antitussive agent; derivative of levorphanol.
• Efalizumab: Immunosuppressive agent; a recombinant humanized anti-CD11a monoclonal antibody.
• Metoclopramide: Antiemetic; stimulant of upper GI motility (prokinetic agent); potent dopamine-receptor antagonist.
• Mycophenolate: Immunosuppressive agent.
• Oxandrolone: Synthetic androgenic anabolic steroid hormone.
• Prilocaine: Intermediate-acting local anesthetic (amide type).
• Simvastatin: Antilipemic agent; hydroxymethylglutaryl-CoA (HMG-CoA) reductase inhibitor (i.e., statin).
• Tetracaine: Local anesthetic.
• Zonisamide: Anticonvulsant; a sulfonamide.

AHFS DI® Essentials: What's New in February 2009

AHFS DI® Essentials

New Monographs:

• None

Revised Monographs:

• Amantadine: Antiviral; antiparkinsonian agent; adamantane derivative.
• Benzocaine (Topical): Local anesthetic.
• Clopidogrel: Platelet-aggregation inhibitor; thienopyridine derivative.
• Drotrecogin Alfa: Biosynthetic (recombinant DNA origin) form of human activated protein C with antithrombotic, anti-inflammatory, and profibrinolytic properties.
• Ergocalciferol: A vitamin D analog.
• Ezetimibe: Antilipemic agent; cholesterol absorption inhibitor.
• Influenza Virus Vaccine Inactivated: Inactivated virus vaccine.
• Influenza Virus Vaccine Live Intranasal: Live, attenuated virus vaccine.
• Lidocaine (Local): Intermediate-acting local anesthetic (amide type).
• Montelukast: Antiasthmatic agent; leukotriene modifier.
• Nelfinavir: Antiretroviral; HIV protease inhibitor (PI).
• Oseltamivir: Antiviral; neuraminidase inhibitor; sialic acid analog.
• Rimantadine: Antiviral; adamantane derivative.
• Simvastatin: Antilipemic agent; hydroxymethylglutaryl-CoA (HMG-CoA) reductase inhibitor (i.e., statin).
• Tinzaparin: Anticoagulant; a low molecular weight heparin.
• Zafirlukast: Antiasthmatic agent; leukotriene-receptor antagonist.
• Zanamivir: Antiviral; neuraminidase inhibitor; sialic acid analog.
• Zileuton: Antiasthmatic agent; a leukotriene synthesis inhibitor.
  

AHFS DI® Essentials: What's New in December 2008

AHFS DI® Essentials: What's New in December 2008

New Monographs:

• None

Revised Monographs:

• Etidronate: Synthetic bisphosphonate; bone resorption inhibitor.
• Fosphenytoin: Hydantoin-derivative anticonvulsant; prodrug of phenytoin.
• Ibandronate: Synthetic bisphosphonate; bone resorption inhibitor.
• Pamidronate: Synthetic bisphosphonate; bone resorption inhibitor.
• Phenytoin: Phenytoin is a hydantoin-derivative anticonvulsant.
• Risedronate: Synthetic bisphosphonate; bone resorption inhibitor.
• Zoledronic Acid: Synthetic bisphosphonate; bone resorption inhibitor.

AHFS DI® Essentials: What's New in November 2008

AHFS DI® Essentials: What's New in November 2008

New Monographs

• None

Revised Monographs

• Abacavir: Antiretroviral: nucleoside reverse transcriptase inhibitor (NRTI).
• Albumin Human: Albumin human, a protein colloid, is a sterile solution of serum albumin prepared by fractionating pooled plasma from healthy human donors.
• Amantadine: Antiviral; antiparkinsonian agent; adamantane derivative.
• Azithromycin: Antibacterial; an azalide, a subclass of macrolide antibiotics.
• Brompheniramine: First generation antihistamines; alkylamine (propylamine) derivatives.
• Carbinoxamine: First generation antihistamine; an ethanolamine derivative.
• Cefditoren: Antibacterial; β-lactam antibiotic; aminothiazolyl derivative third generation cephalosporin.
• Cefepime: Antibacterial; β-lactam antibiotic; fourth generation cephalosporin.
• Cefotaxime: Antibacterial; β-lactam antibiotic; third generation cephalosporin.
• Cefotetan: Antibacterial; β-lactam antibiotic; cephamycin.
• Cefpodoxime: Antibacterial; β-lactam antibiotic; aminothiazolyl third generation cephalosporin.

AHFS DI® Essentials: What's New in October 2008

AHFS DI® Essentials: What's New in October 2008

New Monographs

• None

Revised Monographs

• Abacavir: Antiretroviral; nucleoside reverse transcriptase inhibitor (NRTI).
• Adalimumab: Biologic response modifier and disease-modifying antirheumatic drug (DMARD); a recombinant DNA-derived human immunoglobulin G1 (IgG1) monoclonal antibody specific for human tumor necrosis factor (TNF; TNF-α).
• Atazanavir: Antiretroviral; HIV protease inhibitor (PI).
• Atomoxetine: Selective norepinephrine reuptake inhibitor.
• Darunavir: Antiretroviral; HIV protease inhibitor (PI).
• Didanosine: Antiretroviral; nucleoside reverse transcriptase inhibitor (NRTI).
• Efavirenz: Antiretroviral; nonnucleoside reverse transcriptase inhibitor (NNRTI).
• Emtricitabine: Antiretroviral; nucleoside reverse transcriptase inhibitor (NRTI).

AHFS DI Essentials: What's New in August/September 2008

AHFS DI® Essentials: What's New in August/September

New Monographs

• Aluminum chloride (Topical): Antiperspirant.
• Chloral Hydrate: Sedative and hypnotic.
• Citrates: Alkalinizing agents.
• Corticotropin: A polypeptide hormone secreted by the basophilic cells of the anterior pituitary; stimulates the adrenal cortex to secrete cortisol and other hormones.
• Cyclopentolate: Mydriatic and cycloplegic; tertiary amine antimuscarinic.
• Deferasirox: Heavy metal antagonist; chelating agent for iron.
• Dextrose: Carbohydrate caloric agent; monosaccharide.
• Ethacrynic Acid: A loop-type diuretic and antihypertensive agent.
• Etravirine: Antiretroviral; nonnucleoside reverse transcriptase inhibitor (NNRTI).
• Glucagon: Antihypoglycemic agent; biosynthetic (recombinant DNA-derived) form of human glucagon hormone prepared using special laboratory strains of nonpathogenic Escherichia coli or Saccharomyces cerevisiae.
• Homatropine: Mydriatic and cycloplegic; tertiary amine antimuscarinic.
• Lenalidomide: Biologic response modifier; thalidomide analog with immunomodulatory, antineoplastic, and antiangiogenic activity.